To evaluate the protective role of BRB in Nonalcoholic Steatohepatitis (NASH), a study demonstrated its inhibitory role on NLRP3 inflammasome activation and the subsequent pyroptosis process. Here, NLRP3 is linked to metabolic dysfunction-associated steatohepatitis.